These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30590105)

  • 41. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease].
    Wang YS; Zhou JP; Wei ZF; Tian QY; Zhou HX; Zhang YX
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1199-202, 1205. PubMed ID: 17715026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Th17 Cells Induce Dopaminergic Neuronal Death via LFA-1/ICAM-1 Interaction in a Mouse Model of Parkinson's Disease.
    Liu Z; Huang Y; Cao BB; Qiu YH; Peng YP
    Mol Neurobiol; 2017 Dec; 54(10):7762-7776. PubMed ID: 27844285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation.
    Liu Y; Hu J; Wu J; Zhu C; Hui Y; Han Y; Huang Z; Ellsworth K; Fan W
    J Neuroinflammation; 2012 May; 9():98. PubMed ID: 22624500
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease via promoting mitophagy.
    Hu ZL; Sun T; Lu M; Ding JH; Du RH; Hu G
    Brain Behav Immun; 2019 Oct; 81():509-522. PubMed ID: 31288070
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.
    Pattarini R; Smeyne RJ; Morgan JI
    Neuroscience; 2007 Mar; 145(2):654-68. PubMed ID: 17258864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early activation of Egr-1 promotes neuroinflammation and dopaminergic neurodegeneration in an experimental model of Parkinson's disease.
    Yu Q; Huang Q; Du X; Xu S; Li M; Ma S
    Exp Neurol; 2018 Apr; 302():145-154. PubMed ID: 29337144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice.
    Samantaray S; Knaryan VH; Shields DC; Cox AA; Haque A; Banik NL
    Mol Neurobiol; 2015 Oct; 52(2):1054-66. PubMed ID: 26108182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson's disease.
    Ding W; Lin H; Hong X; Ji D; Wu F
    Toxicology; 2020 Apr; 436():152437. PubMed ID: 32169474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model.
    Rai SN; Yadav SK; Singh D; Singh SP
    J Chem Neuroanat; 2016 Jan; 71():41-9. PubMed ID: 26686287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model.
    Zhang Y; Qin L; Xie J; Li J; Wang C
    Life Sci; 2020 Jul; 253():117745. PubMed ID: 32376269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson's disease.
    Singh S; Mishra A; Mohanbhai SJ; Tiwari V; Chaturvedi RK; Khurana S; Shukla S
    Free Radic Biol Med; 2018 Dec; 129():73-87. PubMed ID: 30176346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic suppression of collapsin response mediator protein 2 phosphorylation improves outcome in methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's model mice.
    Togashi K; Hasegawa M; Nagai J; Tonouchi A; Masukawa D; Hensley K; Goshima Y; Ohshima T
    Genes Cells; 2019 Jan; 24(1):31-40. PubMed ID: 30375127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson's disease.
    Lu J; Dou F; Yu Z
    J Neuroinflammation; 2019 Dec; 16(1):273. PubMed ID: 31878950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cdk5/p25 specific inhibitory peptide TFP5 rescues the loss of dopaminergic neurons in a sub-acute MPTP induced PD mouse model.
    Zhang Q; Xie H; Ji Z; He R; Xu M; He Y; Huang J; Pan S; Hu Y
    Neurosci Lett; 2016 Oct; 632():1-7. PubMed ID: 27542341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PRDX6 Exacerbates Dopaminergic Neurodegeneration in a MPTP Mouse Model of Parkinson's Disease.
    Yun HM; Choi DY; Oh KW; Hong JT
    Mol Neurobiol; 2015 Aug; 52(1):422-31. PubMed ID: 25193021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice.
    Oliveira SR; Dionísio PA; Gaspar MM; Ferreira MBT; Rodrigues CAB; Pereira RG; Estevão MS; Perry MJ; Moreira R; Afonso CAM; Amaral JD; Rodrigues CMP
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway.
    Teng X; Sakai T; Liu L; Sakai R; Kaji R; Fukui K
    J Neurochem; 2006 May; 97(4):1126-35. PubMed ID: 16686692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m
    Gong X; Huang M; Chen L
    CNS Neurosci Ther; 2024 Mar; 30(3):e14441. PubMed ID: 37735974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.